(Q54326061)

English

Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities.

scientific article published on 4 October 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Therapy of 1,025 severely ill patients with complicated infections in a German multicenter study: safety profile and efficacy of tigecycline in different treatment modalities. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

author name string

Klaus-Friedrich Bodmann

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Wolfgang R Heizmann

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Christof von Eiff

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Christian Petrik

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Peter-Andreas Löschmann

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

Christian Eckmann

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

publication date

4 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

58

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

282-294

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

The Antibiotic Development Pipeline for Multidrug-Resistant Gram-Negative Bacilli: Current and Future Landscapes

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007).

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Skin and soft tissue infection: microbiology and epidemiology

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Efficacy and safety of tigecycline: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Excess deaths associated with tigecycline after approval based on noninferiority trials

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline use in serious nosocomial infections: a drug use evaluation.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Operative and nonoperative therapy of intraabdominal infections

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Risk stratification in emergency surgical patients: is the APACHE II score a reliable marker of physiological impairment?

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Tigecycline treatment of critically ill patients: the LatinUser experience.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock*

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Resistance trends and in vitro activity of tigecycline and 17 other antimicrobial agents against Gram-positive and Gram-negative organisms, including multidrug-resistant pathogens, in Germany

1 reference

https://api.crossref.org/works/10.1159%2F000342451

21 January 2018

Identifiers

10.1159/000342451

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/23052187

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54326061&oldid=1235382495"